Your browser doesn't support javascript.
loading
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphoma.
Chow, Victor A; Rajendran, Joseph G; Fisher, Darrell R; Appelbaum, Frederick R; Cassaday, Ryan D; Martin, Paul S; Holmberg, Leona A; Gooley, Theodore A; Stevenson, Philip A; Pagel, John M; Green, Damian J; Press, Oliver W; Gopal, Ajay K.
Afiliação
  • Chow VA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Rajendran JG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Fisher DR; Department of Radiology, University of Washington, Seattle, WA, USA.
  • Appelbaum FR; Versant Medical Physics and Radiation Safety, Richland, WA, USA.
  • Cassaday RD; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Martin PS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gooley TA; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Stevenson PA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Pagel JM; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Green DJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Press OW; Public Health Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gopal AK; Public Health Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Am J Hematol ; 95(7): 775-783, 2020 07.
Article em En | MEDLINE | ID: mdl-32243637

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article